Hepatitis A (Live) Vaccine (Changchun Institute of Biological Products)

甲型肝炎减毒活疫苗(长春生物制品研究所)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis A (Live) Vaccine (Changchun Institute of Biological Products)

Drug Alias NameHAVAC海威克

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis A

Global Approved IndicationsHepatitis A

Approved Indications in ChinaHepatitis A

Original Approved Country/TerritoryMainland China

Original Approved Date2000/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesChangchun Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChangchun Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsHepatitis A

Inactive IndicationsN/A

Other Information

ATC CodeJ07BC02